Reduction of renal function by angiotensin-converting enzyme inhibitors: effect of verapamil.
Bitar
R
R
Martín
B
B
López-Novoa
J M
JM
Macías-Nuñez
J F
JF
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000139:chemically induced / Q000209:etiology; D008297:Male; D014700:Verapamil / Q000009:adverse effects / Q000627:therapeutic use*
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D014700:Verapamil